Syntheses

3-Chloro-4-hydroxybenzylamine
4-Hydroxybenzylamine (300 mg, 2.44 mmol) was dissolved in a mixture of 1M hydrochloric acid in acetic acid (5 mL) and N,N-dimethylformamide (0.5 mL). Sulfuryl chloride (414 µL, 5.12 mmol) was added and the precipitate formed upon stirring (RT, 2 h) was separated by centrifugation, washed with acetic acid (3 x 5 mL) and methylene chloride and left to dry. The product (containing ≈ 6 % impurity) was used without further purification, yield 264 mg (69 %).
1 H NMR (300 MHz, CD 3 OD, TMS): δ = 7.44 (d, 1H, J = 1.9 Hz, H(1)); 7.22 (dd, 1H, J 1 = 8.3 Hz, J 2 = 1.8 Hz, H(2); 6.97 (d, 1H, J = 8.4 Hz, H(1); 4.00 (s, 2H, H(4)).
5(6)-Carboxy-2',7'-dichlorofluorescein
Trimellitic anhydride (1g, 5.21 mmol) and 4-chlororesorcinol (1.51g, 10.4 mmol) were stirred in methanesulfonic acid (25 mL) at 145°C for 1 h. The mixture was allowed to cool to RT and water (400 ml) was added. The crude product was washed thoroughly with water (1.5 L), dried and used without further purification, yield 2.36 g (98 %).
5(6)-(3-Chloro-4-hydroxy-benzylaminocarboxy)-2',7'-dichlorofluorescein (1B)
(5,6)-Carboxy-2',7'-dichlorofluorescein (350 mg, 0.62 mmol), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (166 mg, 0.87 mmol) and Nhydroxysuccinimide (100 mg, 0.87 mmol) were stirred in dry N,N-dimethylformamide (5 ml) for 1.5 h at RT. To the solution of NHS ester obtained were added 3-chloro-4-hydroxybenzylamine (205 mg, 1.30 mmol) and ethyldiisoproylamine (301 µL, 1.73 mmol)).
After 4 h, the crude product was precipitated and washed with water, dried and purified by column chromatography (silica gel, 40 -63 µm), eluent methylene chloride / methanol / acetic acid 98 / 2 / 0.25. Eluate containing product was concentrated to 5 ml, precipitated and washed with water (4 x 100 mL), drying yielded 211 mg (46 %). 1 H NMR (300 MHz, CD 3 OD containing 0.02 M NH 3 , TMS): δ = 8.49 (d, 0.5H, J = 1.3 Hz, H(5a)); 8. 01 -8.15 (m, 1.5H, H(4a,4b,5b) ); 7.69 (d, 0.5H, J = 1.0 Hz, H(3b)); 7.33 -7.39 (m, 1H, H(3a,7)); 7.30 (d, 0.5H, J = 1.8 Hz, H(7)); 7.16 -7.22 (dd, 0.5H, J 1 = 8.2 Hz, J 2 = 2.0 Hz, H(9)); 7.11 (d, 2.5H, J = 1.6
Hz, H(2,9)); 6.82 -6.93 (dd, 1H, J 1 = 8.3 Hz, J 2 = 14.2 Hz, H(8)); 6.60 (s, 2H, H(1)); 4. 43 -4.56 (d, 2H, H(6) 
5(6)-(4-Methyl-1-piperazinylcarboxy)-2',7'-dichlorofluorescein (1C)
After preparing the NHS ester as described for 1B, N-methylpiperazine (175 µL, 1.58 mmol) and ethyldiisoproylamine (301 µL, 1.73 mmol)) were added and the mixture was stirred for 4
h. Repeated precipitation with n-hexane (6 x 5 mL) afforded an oily residue which was purified by column chromatography, eluent methylene chloride / methanol / concentrated Sulforhodamine B-4'-(N-(3,5-dichloro-4-hydroxyphenyl) )sulfonamide (2A)
4-Amino-2,6-dichlorophenol (17 mg, 0.096 mmol) and triethylamine (13.8 µL, 0.010 mmol)
were dissolved in anhydrous N,N-dimethylformamide (0.3 mL), the mixture was cooled to 0°C and lissamine rhodamine B (50 mg, 0.087 mmol) was added. After stirring for 4h at 0°C
and 12h at RT, the crude product was precipitated with n-hexane (6 x 5 mL) and purified by column chromatography, eluent methylene chloride / methanol 96 / 4 1, yield 28 mg (45 %). Sulforhodamine B-4'-(N-(3-azapentane-1,5-diyl) 1, 
The preparation of 3A is described elsewhere 1, 
The preparation of 3B is described elsewhere 1, 6, 7, 4:9, 1,6,7,12-Tetrachloroperylene-3,4:9,10-tetracarboxylic bisanhydride (3 g, 5.66 mmol) was dissolved in 1-methyl-2-pyrrolidone (200 mL) at 110 °C. 4-Amino-2,6-dichlorophenol (1.04 g, 5.84 mmol), 2,6-diisopropylaniline (1.2 mL, 6.37 mmol) and propionic acid (100 mL) were added, the mixture was flushed with nitrogen and stirred at 110 °C for 22 h. 5 % aqueous NaCl (800 mL) was added, the orange precipitate was filtered, washed with water, dried and 6, 7, 4:9, 4B was prepared in the same way as 4A, 4-Amino-2-chlorophenol (813 mg, 5.66 mmol) was used instead of the dichloro compound, yield 1.41 g (31 % -1,6,7,12-tetrachloroperylene-3,4:9,10-tertracarboxylic N- (3, 6, 7, 4:9, A mixture of 4A (70 mg, 0.082 mmol), 1-methyl-2-pyrrolidone (7 mL), phenol (77mg, 0.82 mmol) and potassium carbonate (91 mg, 0.66 mmol) was stirred at 110°C for 15 h. 50 mL of 20 % aqueous NaCl containing 0.7 M HCl were added, the purple precipitate was filtered, washed with water, dried and purified by column chromatography, eluent toluene / ethanol 99 / 1, yield 54 mg (61 %). (9)); 6.98 (8H, t, J = 6.5 Hz, H(7)); 6.11 (1H, s, H(10)); 2.71 (2H, quint, J = 6.4 Hz , H(4));
1.14 (12H, d, J = 6.6 Hz, H (5) 6, 7, 4:9, -1,6,7,12-tetraphenoxyperylene-3,4:9,10-tertracarboxylic bisimide (5D) A mixture of 4D (800 mg, 1.05 mmol), 1-methyl-2-pyrrolidone (50 mL), phenol (950 mg, 10.1 mmol) and potassium carbonate (1.1 g, 7.96 mmol) was stirred at 110°C for 3.5 h. 50 mL of 15 % aqueous NaCl containing 0.3 M HCl were added, the purple precipitate was filtered, washed with dilute aqueous NaHCO 3 , dried and purified by column chromatography, eluent methylene chloride / methanol 98 / 2, yield 681mg (65 % 7, 4:9, 4A (175 mg, 0.24 mmol) was stirred in a mixture of morpholine (3 mL, 35 mmol) and 1-methyl-2-pyrrolidone (3 mL) at 40°C for 2 h. 50 ml 15 % aqueous NaCl containing 0.4 M HCl were added, the green precipitate was filtered, washed with water, dried and purified by column chromatography, eluent methylene chloride / methanol 50 / 1, yield 144 mg (75 %). 7, 4:9, 6D was prepared in the same way as 6A, 4D (180 mg, 0.21 mmol) was used as starting LumRed stands for LumogenRed (1, 6, 7, Sulforhodamine B-4'-(N-(3,5-dichloro-4-hydroxyphenyl) MALDI-TOF spectrum of 2A Sulforhodamine B-4'-(N-(3-azapentane-1,5-diyl) MALDI-TOF spectrum of 2C 
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